This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Controlled drug prescription

Authoring team

From Monday 14th November 2005 you are required to ensure that all prescriptions for controlled drugs:

  • are written indelibly
  • be in ink or otherwise indelible
  • be signed in the prescriber's own handwriting and dated (NB date does not have to be handwritten)
  • specify the prescriber's address
  • state the name and address of the patient (and age if under 12 years) (2,3)
  • state the name and form of the drug (e.g. capsules), even if only one form exists
  • state the strength of the preparation, where more than one strength is available
  • state the dose
  • state the total quantity of the preparation, or the number of dose units, in both words and figures (except for temazepam)
  • if issued by a dentist, state the words 'for dental treatment only'.

Note that all details, except for the signature, no longer have to be handwritten.

Reference:

  1. Letter from Head of Medicines Management Coventry PCT (November 14th 2005). Requirement to handwrite CD prescriptions abolished
  2. National Prescribing Centre (December 2005). A guide to good practice in the management of controlled drugs in primary care (England)
  3. MeReC Extra (January 2006):20:2.

 

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.